Redeye updates its estimates following Arise’s Q1 report yesterday, which presented a solid set of numbers that beat our estimates. The main reason for the beat was an FX effect related to the revaluation of earn-outs in a few projects under construction. However, Arise also realised a higher electricity price per MWh than we counted on, combined with lower-than-expected costs, which further improved the EBITDA. We think the Q1 report was another step in reaching the financial targets of 2024-2025, as Arise is accelerating several projects in its development portfolio.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/